Target intelligence / Profile preview

CTP synthase 2 (CTPS2)

Target
CTPS2
Molecular classification
Enzyme, Metabolic enzyme
01

Overview

CTP synthase 2 is an enzyme encoded by the *CTPS2* gene and is the **rate-limiting enzyme for the synthesis of cytidine triphosphate (CTP) from uridine triphosphate (UTP)**, catalyzing an ATP-dependent amidation using glutamine or ammonia as nitrogen source[1][2][3]. This step is critical for the de novo synthesis of cytosine nucleotides, central to **DNA and RNA synthesis** and general cellular metabolism. CTPS2 activity is tightly regulated allosterically and can form dynamic intracellular filaments associated with changes in metabolic state[5]. Increased CTPS2 activity is observed in proliferating cancer cells, making it a potential target for selective anticancer chemotherapy[1][3]. Loss of CTPS2 function is lethal in certain developmental contexts, consistent with its essential role in nucleotide biogenesis[6].

Other names
CTP synthetase 2Cytidine triphosphate synthase 2PYRG2 (less common)
02

Mechanism of action

Inhibition of CTP synthesis (starving cells of cytidine triphosphate necessary for RNA and DNA synthesis); Feedback inhibition by CTP (end-product inhibits its own synthesis[5])

03

Biological functions

Pyrimidine nucleotide biosynthesisCell proliferationNucleotide homeostasis
04

Disease associations

CancerOther (abnormalities can affect general metabolism and are embryo lethal in model organisms[6])
05

Safety considerations

Inhibition can disrupt nucleotide pools, affecting DNA and RNA synthesis in both cancer and normal rapidly dividing cellsPotential myelosuppression and toxicity to normal proliferating tissues
06

Interacting drugs

Gemcitabine (nucleoside analogs may indirectly target CTPS2)

3 more in the full profile.

07

Biomarkers

Increased CTPS2 expression/activity as proliferation marker in cancer cells[1][3]

Beyond the preview

Go deeper on CTP synthase 2 (CTPS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTP synthase 2 (CTPS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call